
Aurora Cannabis ACB
$ 3.33
-2.99%
Annual report 2025
added 04-11-2026
Aurora Cannabis Cash Conversion Cycle 2011-2026 | ACB
Annual Cash Conversion Cycle Aurora Cannabis
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | 1.45 K | 2.25 K | -1.16 K | - | - | - | - | - |
All numbers in CAD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.25 K | -1.16 K | 847 |
Cash Conversion Cycle of other stocks in the Drug manufacturers industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Assertio Holdings
ASRT
|
467 | $ 18.05 | 0.17 % | $ 116 M | ||
|
Agile Therapeutics
AGRX
|
-206 | - | 10.11 % | $ 58.2 M | ||
|
AcelRx Pharmaceuticals
ACRX
|
-38 | - | 7.5 % | $ 6.35 M | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
-224 | - | 0.86 % | $ 117 M | ||
|
Aerie Pharmaceuticals
AERI
|
460 | - | - | $ 754 M | ||
|
Catalent
CTLT
|
110 | - | - | $ 11.5 B | ||
|
DURECT Corporation
DRRX
|
41.4 | - | - | $ 50.1 M | ||
|
Alimera Sciences
ALIM
|
-128 | - | - | $ 142 M | ||
|
Athenex
ATNX
|
137 | - | -23.39 % | $ 1.76 M | ||
|
Eagle Pharmaceuticals
EGRX
|
139 | - | -39.89 % | $ 27.7 M | ||
|
Endo International plc
ENDP
|
141 | - | - | $ 28.9 M | ||
|
Avadel Pharmaceuticals plc
AVDL
|
192 | - | - | $ 2.06 B | ||
|
Evoke Pharma
EVOK
|
45.7 | - | - | $ 36.6 M | ||
|
Cumberland Pharmaceuticals
CPIX
|
-161 | $ 3.15 | 1.94 % | $ 44.3 M | ||
|
Cronos Group
CRON
|
213 | $ 2.53 | -1.88 % | $ 1.35 B | ||
|
HEXO Corp.
HEXO
|
775 | - | 2.45 % | $ 38.1 M | ||
|
Bausch Health Companies
BHC
|
78.9 | $ 5.58 | -0.53 % | $ 2.04 B | ||
|
Harrow Health
HROW
|
18.3 | $ 36.02 | 0.25 % | $ 1.32 B | ||
|
Canopy Growth Corporation
CGC
|
177 | $ 1.03 | -1.92 % | $ 111 M | ||
|
OrganiGram Holdings
OGI
|
2.92 K | $ 1.38 | -1.44 % | $ 402 M | ||
|
Jupiter Wellness
JUPW
|
-206 | - | - | $ 33.6 M | ||
|
Lannett Company
LCI
|
173 | - | 1.15 % | $ 7.11 M | ||
|
Evolus
EOLS
|
74.8 | $ 4.31 | 0.94 % | $ 278 M | ||
|
Emergent BioSolutions
EBS
|
181 | $ 7.9 | -0.75 % | $ 404 M | ||
|
Tilray
TLRY
|
169 | $ 6.4 | -2.59 % | $ 3.96 B | ||
|
Organogenesis Holdings
ORGO
|
64.5 | $ 2.35 | -1.26 % | $ 309 M | ||
|
Pacira BioSciences
PCRX
|
209 | $ 23.71 | -0.34 % | $ 1.1 B | ||
|
PetIQ
PETQ
|
53.8 | - | 1.64 % | $ 400 M | ||
|
Veru
VERU
|
6.7 | $ 2.4 | 0.84 % | $ 324 M | ||
|
Viatris
VTRS
|
155 | $ 13.43 | -0.33 % | $ 16.1 B | ||
|
ProPhase Labs
PRPH
|
96 | - | - | $ 5.07 M | ||
|
cbdMD
YCBD
|
92 | $ 0.66 | -2.96 % | $ 2.85 M | ||
|
Radius Health
RDUS
|
-53.5 | - | - | $ 1.42 B | ||
|
Recro Pharma
REPH
|
105 | - | -4.76 % | $ 65.3 M | ||
|
OptiNose
OPTN
|
314 | - | - | $ 1.08 B | ||
|
SCYNEXIS
SCYX
|
106 | $ 1.0 | - | $ 49.9 M | ||
|
PLx Pharma
PLXP
|
111 | - | -27.8 % | $ 2.56 M | ||
|
Sonoma Pharmaceuticals
SNOA
|
150 | $ 2.26 | -0.88 % | $ 2.8 M | ||
|
Zomedica Corp.
ZOM
|
154 | - | -0.21 % | $ 98 M | ||
|
Rockwell Medical
RMTI
|
57 | $ 0.91 | -0.02 % | $ 32.7 M | ||
|
China Pharma Holdings
CPHI
|
139 | $ 0.63 | - | $ 2.7 M | ||
|
TherapeuticsMD
TXMD
|
-723 | $ 2.13 | 3.14 % | $ 24.6 M |